doi: 10.11477/mf.1436204411.
[Proton magnetic resonance spectroscopy (1H-MRS)]
[Article in
Japanese]
Affiliations
- PMID: 33762470
- DOI: 10.11477/mf.1436204411
Item in Clipboard
[Proton magnetic resonance spectroscopy (1H-MRS)]
[Article in
Japanese]
No Shinkei Geka.
2021 Mar.
Abstract
Proton magnetic resonance spectroscopy(1H-MRS)is a non-invasive method for evaluating brain function and metabolism. 1H-MRS can quantify low-molecular-weight metabolites in a living brain; it shows their spectra without tracer administration. In this paper, we introduce 1H-MRS and MRS for imaging the distribution of metabolites. The applications of 1H-MRS imaging for several neurological disorders will be outlined.
Similar articles
-
1H-MR Spectroscopy of the Early Developmental Brain, Neonatal Encephalopathies, and Neurometabolic Disorders.Magn Reson Med Sci. 2022 Mar 1;21(1):9-28. doi: 10.2463/mrms.rev.2021-0055. Epub 2021 Aug 21. Magn Reson Med Sci. 2022. PMID: 34421092 Free PMC article.
-
The clinical utility of proton magnetic resonance spectroscopy in traumatic brain injury: recommendations from the ENIGMA MRS working group.Brain Imaging Behav. 2021 Apr;15(2):504-525. doi: 10.1007/s11682-020-00330-6. Brain Imaging Behav. 2021. PMID: 32797399 Free PMC article.
-
The Role of Proton Magnetic Resonance Spectroscopy in Neonatal and Fetal Brain Research.J Magn Reson Imaging. 2025 Jun;61(6):2404-2424. doi: 10.1002/jmri.29709. Epub 2025 Jan 21. J Magn Reson Imaging. 2025. PMID: 39835523 Free PMC article. Review.
-
Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.Neuroradiology. 2022 Jun;64(6):1111-1126. doi: 10.1007/s00234-022-02918-9. Epub 2022 Feb 28. Neuroradiology. 2022. PMID: 35224679 Review.
-
Clinical Imaging of Tumor Metabolism with ¹H Magnetic Resonance Spectroscopy.Magn Reson Imaging Clin N Am. 2016 Feb;24(1):57-86. doi: 10.1016/j.mric.2015.09.002. Magn Reson Imaging Clin N Am. 2016. PMID: 26613876 Review.
Cited by
-
Hydrogen Proton Magnetic Resonance Spectroscopy (MRS) in Differential Diagnosis of Intracranial Tumors: A Systematic Review.Contrast Media Mol Imaging. 2022 May 18;2022:7242192. doi: 10.1155/2022/7242192. eCollection 2022. Contrast Media Mol Imaging. 2022. Retraction in: Contrast Media Mol Imaging. 2023 Sep 14;2023:9805474. doi: 10.1155/2023/9805474. PMID: 35655732 Free PMC article. Retracted.
-
In Vitro MRS of Cells Treated with Trastuzumab at 1.5 Tesla.Int J Mol Sci. 2024 Jan 31;25(3):1719. doi: 10.3390/ijms25031719. Int J Mol Sci. 2024. PMID: 38338997 Free PMC article.
-
Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease.Brain Behav. 2023 Sep;13(9):e3170. doi: 10.1002/brb3.3170. Epub 2023 Jul 26. Brain Behav. 2023. PMID: 37491953 Free PMC article.
-
The cerebral metabolic mechanism of group computer magnanimous therapy based on magnetic resonance spectroscopy: effects on improving magnanimous-enterprising levels of lung cancer patients.Front Psychiatry. 2024 Dec 10;15:1397375. doi: 10.3389/fpsyt.2024.1397375. eCollection 2024. Front Psychiatry. 2024. PMID: 39720429 Free PMC article.
-
Preliminary MRS study of critical values of relevant brain metabolites in elderly Chinese patients with post-stroke cognitive impairment.IBRO Neurosci Rep. 2023 Oct 16;15:287-292. doi: 10.1016/j.ibneur.2023.10.002. eCollection 2023 Dec. IBRO Neurosci Rep. 2023. PMID: 37885832 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
